Myong-Jin Kim, Pharm.D.

Division Director
US Food and Drug Administration

Poster(s):

• (W1230-07-38) Ethanol Solubility of Rate Controlling Polymer in Modified Release Formulation Can Impact Alcohol Dose Dumping: An Assessment Through Principal Component Analysis
  Wednesday, October 23, 2024

  12:30 PM – 1:30 PM MT

• (M1530-02-07) Evaluation of the Pharmacokinetics and Abuse Potential of Intranasally Administered Extended-Release Oxycodone and Naloxone Abuse-Deterrent Formulations Milled to Different Particle Sizes
  Monday, October 21, 2024

  3:30 PM – 4:30 PM MT